T2	Participants 218 261	sleeping sickness treatment with melarsopro
T1	Participants 24 161	encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis
T3	Participants 264 544	To investigate the existence of risk factors, the incidence of encephalopathic syndromes and the relationship between the development of different types of encephalopathies and the clinical outcome was studied in a clinical trial with 588 patients under treatment with melarsoprol
T4	Participants 550 701	38 encephalopathy cases were classified into three types according to the leading clinical picture: coma type, convulsion type and psychotic reactions.
